It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Abundant heterogeneous immune cells infiltrate lesions in chronic inflammatory diseases and characterization of these cells is needed to distinguish disease-promoting from bystander immune cells. Here, we investigate the landscape of non-communicable inflammatory skin diseases (ncISD) by spatial transcriptomics resulting in a large repository of 62,000 spatially defined human cutaneous transcriptomes from 31 patients. Despite the expected immune cell infiltration, we observe rather low numbers of pathogenic disease promoting cytokine transcripts (IFNG, IL13 and IL17A), i.e. >125 times less compared to the mean expression of all other genes over lesional skin sections. Nevertheless, cytokine expression is limited to lesional skin and presented in a disease-specific pattern. Leveraging a density-based spatial clustering method, we identify specific responder gene signatures in direct proximity of cytokines, and confirm that detected cytokine transcripts initiate amplification cascades of up to thousands of specific responder transcripts forming localized epidermal clusters. Thus, within the abundant and heterogeneous infiltrates of ncISD, only a low number of cytokine transcripts and their translated proteins promote disease by initiating an inflammatory amplification cascade in their local microenvironment.
Inflammatory skin diseases involve various different immune cells in a localised area. Here the authors use spatial transcriptomics to show that disease relevant cytokine transcripts are sparsely expressed in lesional skin, yet are associated with local amplification cascades that promote skin inflammation.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Hillig, C. 2 ; Mubarak, M. 3 ; Jargosch, M. 4 ; Farnoud, A. 2 ; Scala, E. 5 ; Kurzen, N. 3
; Pilz, A. C. 6 ; Bhalla, N. 7
; Thomas, J. 3 ; Stahle, M. 1 ; Biedermann, T. 8
; Schmidt-Weber, C. B. 3
; Theis, F. 2
; Garzorz-Stark, N. 9 ; Eyerich, K. 10 ; Menden, M. P. 11
; Eyerich, S. 3
1 Karolinska Institutet, Division of Dermatology and Venereology, Department of Medicine Solna, and Center for Molecular Medicine, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626)
2 Institute of Computational Biology, Helmholtz Zentrum München—German Research Centre for Environmental Health, Neuherberg, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525)
3 Technical University and Helmholtz Center Munich, Center for Allergy and Environment (ZAUM), Munich, Germany (GRID:grid.6936.a) (ISNI:0000000123222966)
4 Technical University and Helmholtz Center Munich, Center for Allergy and Environment (ZAUM), Munich, Germany (GRID:grid.6936.a) (ISNI:0000000123222966); Technical University of Munich, Department of Dermatology and Allergy, Munich, Germany (GRID:grid.6936.a) (ISNI:0000000123222966)
5 Karolinska Institutet, Division of Dermatology and Venereology, Department of Medicine Solna, and Center for Molecular Medicine, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Department of Dermatology and Venerology, Freiburg, Germany (GRID:grid.5963.9)
6 Technical University of Munich, Department of Dermatology and Allergy, Munich, Germany (GRID:grid.6936.a) (ISNI:0000000123222966); Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Department of Dermatology and Venerology, Freiburg, Germany (GRID:grid.5963.9)
7 Biotechnology and Health, KTH Royal Institute of Technology, Department of Gene Technology, School of Engineering Sciences in Chemistry, Stockholm, Sweden (GRID:grid.5037.1) (ISNI:0000000121581746)
8 Technical University of Munich, Department of Dermatology and Allergy, Munich, Germany (GRID:grid.6936.a) (ISNI:0000000123222966)
9 Karolinska Institutet, Division of Dermatology and Venereology, Department of Medicine Solna, and Center for Molecular Medicine, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Technical University of Munich, Department of Dermatology and Allergy, Munich, Germany (GRID:grid.6936.a) (ISNI:0000000123222966)
10 Karolinska Institutet, Division of Dermatology and Venereology, Department of Medicine Solna, and Center for Molecular Medicine, Stockholm, Sweden (GRID:grid.4714.6) (ISNI:0000 0004 1937 0626); Medical Center—University of Freiburg, Faculty of Medicine, University of Freiburg, Department of Dermatology and Venerology, Freiburg, Germany (GRID:grid.5963.9); Unit of Dermatology, Karolinska University Hospital, Department of Dermatology and Venereology, Stockholm, Sweden (GRID:grid.24381.3c) (ISNI:0000 0000 9241 5705)
11 Institute of Computational Biology, Helmholtz Zentrum München—German Research Centre for Environmental Health, Neuherberg, Germany (GRID:grid.4567.0) (ISNI:0000 0004 0483 2525); Ludwig-Maximilians University, Department of Biology, Martinsried, Germany (GRID:grid.5252.0) (ISNI:0000 0004 1936 973X); German Center for Diabetes Research (DZD e.V.), Neuherberg, Germany (GRID:grid.452622.5)




